BioQuest Corp.
BQST • Drug Manufacturers - Specialty & Generic
$0.25
— 0.00 (0.00%)
Current price
EarningsLatest report: Jan 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$7.47M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.12Weak profitability
Financial data as of: Jan 31, 2026, 12:00 AM UTCLast earnings update: Jan 31, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.25
Change0.00%
Shares Out29.90M
Market Cap$7.47M
Enterprise Value$7.86M
52W Range0.07 - 1.00
Beta9.57
P/E-5.34
P/S24.55
P/B-7.69
P/FCF-6.79
EV/Sales25.81
Price$0.25
Change0.00%
Shares Out29.90M
Market Cap$7.47M
Enterprise Value$7.86M
52W Range0.07 - 1.00
Beta9.57
P/E-5.34
P/S24.55
P/B-7.69
P/FCF-6.79
EV/Sales25.81
EV/EBITDA-5.81
EV/FCF-7.14
Earnings Yield-18.73%
FCF Yield-14.72%
Dividend Yield0.00%
Gross Margin29.04%
Oper. Margin-5.74%
Profit Margin-5.41%
Debt/Eq1.92
Current Ratio0.12
Quick Ratio0.12
Volume12.00
Avg Volume43.00
Investment DNA
How strong this company looks for long-term investors
28
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
21/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Weak liquidity · 0.12Weak profitability
Analyst view
No analyst data available now.
Financial Health
Score4 / 20
Debt / Equity: 1.92
Current Ratio: 0.12
Quick Ratio: 0.12
Status: HighRisk
Warnings
- Weak Liquidity
- Weak quick ratio
🧾
No insider activity
No recent insider transactions available.